Skip to main content
Explore URMC

menu

Bladder Cancer: A Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Urothelial Carcinoma

Research Question:
How well does INCB054828 work in treating metastatic or surgically unresectable Urothelial Carcinoma?

Basic Study Information

Purpose:
The primary purpose of this research study is to assess how metastatic or surgically unresectable Urothelial Carcinoma with FGF/FGFR alterations responds to treatment with INCB054828. The other goals of the study are to determine how safe and well tolerated the study drug, INCB054828, is, and to obtain data to try and identify patients who would benefit most from INCB054828.

Location: cancer center
Study Web URL:  https://clinicaltrials.gov/ct2/show/NCT02872714?term=INCB+54828-201&rank=1
Study Reference #: IGUB-16112

Lead Researcher (Principal Investigator)

Lead Researcher: Chunkit Fung

Study Contact Information

Study Coordinator: Park Bogan
Phone: (585) 276-4415
Email: Park_Bogan@URMC.Rochester.edu

Additional Study Details

Return to Search